• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Archives of Pharmaceutical Sciences Ain Shams University
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 6 (2022)
Issue Issue 2
Issue Issue 1
Volume Volume 5 (2021)
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Alafifi, S., Wahdan, S., Elsherbiny, D., Azab, S. (2022). Doxorubicin-induced testicular toxicity: possible underlying mechanisms and promising pharmacological treatments in experimental models.. Archives of Pharmaceutical Sciences Ain Shams University, 6(2), 196-207. doi: 10.21608/aps.2022.155127.1098
Shorouk Alafifi; Sara Wahdan; Doaa Elsherbiny; Samar S Azab. "Doxorubicin-induced testicular toxicity: possible underlying mechanisms and promising pharmacological treatments in experimental models.". Archives of Pharmaceutical Sciences Ain Shams University, 6, 2, 2022, 196-207. doi: 10.21608/aps.2022.155127.1098
Alafifi, S., Wahdan, S., Elsherbiny, D., Azab, S. (2022). 'Doxorubicin-induced testicular toxicity: possible underlying mechanisms and promising pharmacological treatments in experimental models.', Archives of Pharmaceutical Sciences Ain Shams University, 6(2), pp. 196-207. doi: 10.21608/aps.2022.155127.1098
Alafifi, S., Wahdan, S., Elsherbiny, D., Azab, S. Doxorubicin-induced testicular toxicity: possible underlying mechanisms and promising pharmacological treatments in experimental models.. Archives of Pharmaceutical Sciences Ain Shams University, 2022; 6(2): 196-207. doi: 10.21608/aps.2022.155127.1098

Doxorubicin-induced testicular toxicity: possible underlying mechanisms and promising pharmacological treatments in experimental models.

Article 3, Volume 6, Issue 2, December 2022, Page 196-207  XML PDF (474.09 K)
Document Type: Review Article
DOI: 10.21608/aps.2022.155127.1098
Authors
Shorouk Alafifi email ; Sara Wahdan; Doaa Elsherbiny; Samar S Azab
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt
Abstract
Chemotherapy is considered to be the most effective intervention in cancer treatment. The first use of chemotherapy began in the 1940s, unfortunately, its use result in many serious and debilitating side effects which affect human daily activities. Doxorubicin is a powerful antineoplastic drug FDA approved for the management of variety of cancer types including leukemia and lymphoma. however, its clinical use is limited due to its toxic effect to different tissues including testicular toxicity which has bad impact on quality of life to cancer survivors. DOX –induced testicular toxicity is accompanied by defects in sperm analysis including low sperm count, low sperm motility and high sperm abnormalities in addition to affecting on steroidogenesis. This review is intended to discuss the pharmacodynamics and the pharmacokinetics of doxorubicin, beside the possible underlying mechanisms may be contributed to damage of testicles caused by DOX including oxidative stress, inflammation, apoptosis and autophagy. moreover, the assessment of post – chemotherapy testicular toxicity in animals and the promising pharmacological treatment that has been studied in animal models were discussed.
Keywords
testicular toxicity; Doxorubicin; oxidative stress; apoptosis; inflammation
Statistics
Article View: 249
PDF Download: 205
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.